Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

US Patent 12171739 · Granted Dec 24, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds, compositions and methods2025
Antiviral pyrazolopiridinone compounds2025
5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases2025
Imaging methods using deuterated compounds2025
10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazi2024
KRas G12D inhibitors2024
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections2024
Inhibiting agents for bruton's tyrosine kinase2024
Substituted pyrimidines as LRKK2 inhibitors2023
Compounds, compositions, and methods2023
5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases2023
Fused tetracyclic quinazoline derivatives as inhibitors of ErbB22023